These human adipose organoids exhibited mature adipocyte markers, including FABP4 and PLIN1. Finally, in our study, we show that the CRISPRa modulation can significantly reduce tumor size, glycolysis, fatty acid metabolism and uridine use and improve hypoxia and angiogenesis in cancer mouse models. This evidence concerns the gene FABP4 and cancer.